Phase 2 Recurrent Rectal Cancer Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）
Unresectable Locally Recurrent Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University31 enrolled1 locationNCT06767007
Recruiting
Phase 2
Stereotactic Body Radiation Therapy for Unresectable Locally Recurrent Rectal Cancer
Unresectable Locally Recurrent Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University20 enrolled1 locationNCT07297004
Recruiting
Phase 2
Hypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R)
Locally Recurrent Rectal Cancer
Fudan University44 enrolled1 locationNCT07183865
Recruiting
Phase 2
Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer
Locally Recurrent Rectal Cancer
Fudan University221 enrolled1 locationNCT06928584
Recruiting
Phase 2
The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer
Recurrent Rectal Cancer
Fudan University93 enrolled1 locationNCT05628038